Evaluation of urinary proepithelin as a potential biomarker for bladder cancer detection and prognosis in Egyptian patients

Cancer Biomarkers

Volumn 7, Issue 3, 2010, Pages 163-170

  Selmy, Mohamed A ^a   Ibrahim, Gehan H ^a,b   El Serafi, Taher I ^a   Ghobeish, Ammar A ^b  

^a Department of Medical Biochemistry ^*  (Egypt)

^b Suez Canal University Faculty of Medicine   (Egypt)

Author keywords

biomarker; bladder cancer; cancer detection; invasion; Proepithelin

Indexed keywords

CREATININE; PROGRANULIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER STAGING; CONTROLLED STUDY; EGYPT; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN URINE LEVEL; SENSITIVITY AND SPECIFICITY;

AGED; CARCINOMA, TRANSITIONAL CELL; EARLY DETECTION OF CANCER; EGYPT; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; URINALYSIS; URINARY BLADDER NEOPLASMS;

EID: 79954534346     PISSN: 15740153     EISSN: None     Source Type: Journal    
DOI: 10.3233/CBM-2010-0186     Document Type: Article

References (30)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu and M.J. Thun, Cancer statistics, 2009, CA Cancer J Clin 59 (2009), 225-249.
2. M.D. Parkin, F. Bray, J. Ferlay and P. Pisani, Global cancer statistics, 2002, Cancer JClin 55 (2005), 74-108.
3. N.G. El-Mawla, M.N. El-Bolkainy and H.M. Khaled, Bladder cancer in Africa: update, Semin Oncol 28 (2001), 174-178. (Pubitemid 32319391)
4. R.J. Sylvester, A.PM. van der Meijden, W. Oosterlinck, J.A. Witjes, C Bouffioux, L. Denis, D.W.W. Newling and K. Kurth, Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTCtrials, Eur Urol 49 (2006), 466-477.
5. M.F. Botteman, C.L. Pashos, A. Redaelli, B. Laskin and R. Hauser, The health economics of bladder cancer: a com-prehensive review of the published literature, Pharmacoeco-nomics 21 (2003), 1315-1330. (Pubitemid 38041357)
6. S. Weikert, F. Christoph, M. Schrader, H. Krause, K. Miller and M. Müller, Quantitative analysis of survivin mRNA ex-pression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis, Int J Cancer 116 (2005), 100-104. (Pubitemid 40827761)
7. G. Serrero, Autocrine growthfactorrevisited: PC-cell-derived growth factor (progranulin), a critical player in breast cancer tumorigenesis, Biochem Biophys Res Commun 308 (2003), 409-413. (Pubitemid 36945505)
8. Z. He and A. Bateman, Progranulin (granulin-epithelin precur-sor, PC-cell derived growth factor, acrogranin) mediates tissue repair and tumorigenesis, J Mol Med 81 (2003), 600-612. (Pubitemid 37357675)
9. A. Bateman and H.PJ. Bennett, The granulin gene family: from cancer to dementia, Bio Essays 31 (2009), 1245-1254.
10. S.T. Cheung, S.Y. Wong, K.L. Leung, X. Chen, S. So, I.O. Ng and S.T Fan, Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma, Clin Cancer Res 10 (2004), 7629-7636. (Pubitemid 39557526)
11. F. Lovat, A. Bitto, S.Q. Xu, M. Fassan, S. Goldoni, D. Metalli, V. Wubah, P. McCue, G. Serrero, L.G. Gomella, R. Baffa, R.V. Iozzo and A. Morrione, Proepithelin is an autocrine growth factor for bladder cancer, Carcinogenesis 30 (2009), 861-868.
12. R. Lu and G. Serrero, Inhibition of PC cell-derived growth factor (PCDGF, epithelin/granulin precursor) expression by antisense PCDGF cDNA transfection inhibits tumorigenicity of the human breast carcinoma cell line MDA-MB-468, Proc Natl Acad Sci USA 97 (2000), 3993-3998. (Pubitemid 30226075)
13. G. Monami, E.M. Gonzalez, M. Hellman, L.G. Gomella, R. Baff, R.V. Iozzo and A. Morrione, Proepithelin Pro-motes Migration and Invasion of 5637 Bladder Cancer Cells throughtheActivation of ERK1/2 andthe Formation of a Pax-illin/FAK/ERK Complex, Cancer Res 66 (2006), 7103-7110. (Pubitemid 44197687)
14. G. Sauter, F. Algaba, M. Amin, C Busch, J. Chevill, T. Gasser, D.J. Grignon, F. Hofstadter, A. Lopez-Beltran and J.I. Epstein, Tumours of the urinary system: non-invasive urothelial neo-plasias, in: WHO Classification of Tumours of the Urinary System andMale Genital Organs, J.N. Eble, G. Sauter, J.I. Epstein and I. Sesterhenn, eds, Lyon: IARCC Press, 2004, pp. 29-34.
15. V.B. Lokeshwar and M.S. Soloway, Current bladder tumor tests: does their projected utility fulfill clinical necessity? J Urol 165 (2001), 1067-1077. (Pubitemid 32210202)
16. H.G. van der Poel and F.M. Debruyne, Canbiological markers replace cystoscopy? An update, Curr Opin Urol 11 (2001), 503-509. (Pubitemid 32783698)
17. J. Zhou, G. Gao, J.W. Crabb and G. Serrero, Purification of an autocrine growth factor homologous with mouse epithelin precursor from a highly tumorigenic cell line, J Biol Chem 268(1993), 10863-10869. (Pubitemid 23162265)
18. B.W. van Rhijn, H.G. van der Poel and T.H. van der Kwast, Urine Markers for Bladder Cancer Surveillance: A Systematic Review, Eur Urol 47 (2005), 736-748. (Pubitemid 40745338)
19. J. Landman, Y. Chang, E. Kavaler, M.J. Droller and B.C. Liu, Sensitivity and specificity of NMP-22, telomerase and BTA in the detection of human bladder cancer, Urology 52 (1998), 398-402. (Pubitemid 28399904)
20. M.O. Hoque, J. Lee, S. Begum, K. Yamashita, J.M. Engles, M. Schoenberg, W.H. Westra and D. Sidransky, High-throughput molecular analysis of urine sediment forthe detection of blad-der cancer by high-density single-nucleotide polymorphism array, Cancer Res 63 (2003), 5723-5726. (Pubitemid 37187467)
21. Z. He and A. Bateman, Progranulin gene expression regulates epithelial cell growth and promotes tumor growth in vivo, Cancer Res 59 (1999), 3222-3229. (Pubitemid 29316026)
22. Z. He, A. Ismail, L. Kriazhev and A. Bateman, Progranulin (PC-cell-derived growth factor/acrogranin) regulates invasion and cell survival, Cancer Res 62 (2002), 5590-5596.
23. W. Tangkeangsirisin and G. Serrero, PC cell-derived growth factor (PCDGF/GP88, progranulin) stimulates migration, in-vasiveness and VEGF expression in breast cancer cells, Car-cinogenesis 25 (2004), 1587-1592. (Pubitemid 39214300)
24. K. Azuma, M. Tanaka and T. Uekita, Tyrosine phosphoryla-tion of paxillin affects the metastatic potential of human os-teosarcoma, Oncogene 24 (2005), 4754-4764. (Pubitemid 41076293)
25. A. Morrione, M. Navarro, G. Romano, M. Dews, K. Reiss, B. Valentinis, B. Belletti and R. Baserga, The role of the insulin receptor substrate-1 in the differentiation of rat hippocampal neuronal cells, Oncogene 20 (2001), 4842-4852. (Pubitemid 32803154)
26. A.S. Feldman, J. Banyard, C-L. Wu, W. ScottMcDougal and B.R. Zetter, Cystatin B As a tissue and urinary biomarker of bladder cancer recurrence and disease progression, Clin Cancer Res 15 (2009), 1024-1031.
27. M. Buscarini, M.L. Quek, P. Gill, G. Xia, D.I. Quinin and J.P. Stein, Molecular prognostic factors in bladder cancer, BJU international 95 (2004), 739-742.
28. M. Han and M.P. Schoenberg, The use of molecular diagnos-tics in bladder cancer, Urol Oncol 5 (2000), 87-92. (Pubitemid 30182534)
29. V. Margulis, Y. Lotan and S.F. Shariat, Survivin: a promis-ing biomarker for detection and prognosis of bladder cancer, World J Urol 26 (2008), 59-65.
30. J.C. Ho, YC. Ip, S.T. Cheung, YT Lee, K.F. Chan, S.Y. Wong and S.T Fan, Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma, Hepatology 47 (2008), 1524-1532. (Pubitemid 351702736)